Imricor Medical Systems Inc宣布已成功完成其FDA审批通道内所有医疗设备的人因工程研究。
该项研究的顺利完成标志着公司在获得美国食品药品监督管理局(FDA)批准方面迈出了重要一步,为其医疗设备产品的商业化进程奠定了坚实基础。
Imricor Medical Systems Inc宣布已成功完成其FDA审批通道内所有医疗设备的人因工程研究。
该项研究的顺利完成标志着公司在获得美国食品药品监督管理局(FDA)批准方面迈出了重要一步,为其医疗设备产品的商业化进程奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.